Recognition of nucleic acids enables detection of diverse pathogens by a limited number of innate 18 immune receptors but also exposes the host to potential autoimmunity. At least two members of the 19 Toll-like receptor (TLR) family, TLR7 and TLR9, can recognize self RNA or DNA, respectively.
144
Based on these results, we considered the possibility that Syntenin-1 negatively regulates TLR7 145 when bound to Unc93b1. A previous study has suggested that Syntenin-1 can inhibit TLR4 and IL-1 146 receptor (IL-1R) signaling by interfering with the interaction between IRAK-1 and TRAF6, but whether 147 Syntenin-1 could inhibit TLR7 signaling was not examined 27 . To test this possibility, we measured the 148 effect of Syntenin-1 overexpression on TLR7 activation in HEK293T cells, using an NF-kB luciferase 149 reporter system. Increasing expression of Syntenin-1 substantially reduced TLR7 signaling (Fig. 3d ),
150
whereas activation of NF-kB by TNFα was not affected (Fig. 3e ).
151
Since Unc93b1 PKP had no effect on TLR9 signaling, we asked whether Syntenin-1 recruitment 152 was specific to TLR7. The increased association between Unc93b1 and Syntenin-1, as seen before ( Fig.   153 3c), only occurred after TLR7 activation, as stimulation with TLR9 ligand did not change the levels of 154 Syntenin-1 bound to Unc93b1 (Fig. 3f) . Presumably, the selective inhibition of TLR7 signaling is based 155 on the interaction between Syntenin-1 with Unc93b1, which brings Syntenin-1 in close proximity to 156 TLR7. In an accompanying paper, we demonstrate that TLR9 is released from Unc93b1 within 157 endosomes while TLR7 and Unc93b1 remain associated 28 . This mechanism likely explains why the 158 disruption of Syntenin-1 inhibition with the Unc93b1 PKP mutation does not impact TLR9. Altogether, 159 these results identify Syntenin-1 as an Unc93b1-binding protein that specifically inhibits TLR7 signaling. analyses of cellular phosphorylated proteins have identified potential phosphorylation of two serine 166 residues (Ser547, Ser550) within the Unc93b1 C-terminal tail 29 . Two triple alanine mutations that 167 encompass these serines (Unc93b1 DNS/AAA and Unc93b1 DES/AAA ) were identified in our original screen as 168 leading to enhanced TLR7 responses ( Fig. 1a ), so we considered whether the disruption of 169 phosphorylation at Ser547 and Ser550 underlies the defective regulation observed for these mutants. In 170 fact, mutation of Ser547 (Unc93b1 S547A ), Ser550 (Unc93b1 S550A ), or both serines (Unc93b1 S547A/S550A ) to 171 alanine was sufficient to enhance TLR7 responses to levels comparable to Unc93b1 PKP (Figs. 4a-c). To 172 examine directly whether Ser547 and Ser550 of Unc93b1 are phosphorylated in cells, we generated 173 polyclonal antisera specific for phosphorylated Ser547 and Ser550 within the Unc93b1 C-terminal tail 174 ( Fig. S5a ). Using affinity-purified IgG from these sera, we confirmed that Unc93b1 is phosphorylated at 175 these residues when expressed in RAW cells; mutation of either serine reduced detection by the phospho-176 specific Unc93b1 antibodies, while mutation of both serines completely abrogated detection (Fig. S5b ).
177
Based on these results, we conclude that at least some fraction of Unc93b1 is phosphorylated at Ser547 or 178 Ser550 and that phosphorylation of these residues is necessary to limit TLR7 responses.
179
Next, we sought to determine whether phosphorylation of Ser547 and Ser550 was inhibiting 180 TLR7 signaling through the same mechanism that we uncovered for Unc93b1 PKP . Combining the 181 Unc93b1 PKP mutation with Unc93b1 S547A , Unc93b1 S550A , or Unc93b1 S547A/S550A did not further enhance 182 TLR7 responses beyond that observed in Unc93b1 PKP -expressing cells ( Fig. 4a ), suggesting that each 183 mutation acts by disrupting the same mechanism. Indeed, Syntenin-1 recruitment to Unc93b1 after R848 184 stimulation was impaired in Unc93b1 S547A/S550A -expressing cells ( Fig. 4d ), indicating that phosphorylation 185 of Ser547 and Ser550 is required for binding of this negative regulator of TLR7 signaling.
186
In light of these results, the defect in Syntenin-1 recruitment associated with the Unc93b1 PKP 187 mutation could either be due to disruption of residues required for direct interaction with Syntenin-1, or, 188 alternatively, Unc93b1 PKP may fail to interact with the kinase(s) that phosphorylate(s) Ser547 and Ser550.
189
To distinguish between these possibilities, we examined phosphorylation of Ser547 and Ser550 in 190 Unc93b1 PKP -expressing cells and observed that levels of phosphorylation were equivalent to the levels in 191 Unc93b1 WT cells (Fig. 4e) . These results support a model in which Syntenin-1 binding to Unc93b1 192 requires specific residues within the C-terminal tail as well as phosphorylation of Ser547 and Ser550 ( Fig.   193 4f). While some Syntenin-1 is associated with Unc93b1 in unstimulated cells, the interaction is further 194 increased upon TLR7 signaling. Thus, the mechanism we describe appears not only to influence the initial 195 threshold of TLR7 activation but also operates as a negative feedback loop to shut down TLR7 signaling.
196
The signals leading to this increased recruitment as well as the identities of the kinases and phosphatases reported: P532T, Y539D, D545V, and D545Y ( Fig. 4g ). We tested for any functional consequences of 206 these variants by expressing each in HEK293T cells together with TLR7. Three of the variants 207 (Unc93b1 Y539D , Unc93b1 D545V , and Unc93b1 D545Y ) increased TLR7 responses relative to Unc93b1 WT , 208 although Unc93b1 Y539D , and to a lesser extent Unc93b1 D545Y , also increased TLR5 responses ( Fig. 4g ).
209
These alleles are too rare to be linked to autoimmune disorders via genome-wide association studies, but 210 the results suggest that modulation of the regulatory mechanism we describe here can influence TLR7 211 activation thresholds and consequently may impact the likelihood of certain autoimmune diseases.
213
Mutation of the C-terminal regulatory region in Unc93b1 leads to TLR7-dependent 214 autoimmunity 215 Finally, we sought to test the importance of Unc93b1/Syntenin-1 regulation of TLR7 for self 216 versus non-self discrimination in vivo. We considered that analysis of Syntenin-1 deficient mice could 217 be complicated for multiple reasons. First, Syntenin-1 has been implicated in the regulation of 218 multiple transmembrane proteins, and Syntenin-1 deficient mice show pleiotropic effects on the 219 immune system and the microbiota 30 . In addition, Syntenin-2, a highly homologous protein may 220 compensate for Syntenin-1 deficiency. To sidestep these potential issues, we introduced the 221 Unc93b1 PKP mutation into the germline of mice using Cas9 genome editing (Fig. S6a ). This mutation 222 disrupts interaction with Syntenin-1 but should leave other Syntenin-1 functions unaffected. We 223 obtained an Unc93b1 WT/PKP founder, backcrossed this founder to C57BL/6J for 1 generation, and 
232
The phenotype of Unc93b1 PKP/PKP mice demonstrates that disruption of the Unc93b1/Syntenin- 
238
Consistent with the model that Syntenin-1 alters the activation threshold of TLR7, enhanced responses 239 to R848 were most evident at low ligand concentrations ( Fig. 5e ). In line with the enhanced cytokine 240 production, macrophages from Unc93b1 PKP/PKP mice showed accelerated and stronger assembly of the 241 Myddosome complex downstream of TLR7 activation ( Fig. 5f ). These enhanced TLR7 responses were 242 not due to differences in Unc93b1 expression, as Unc93b1 protein levels were similar in BMMs from 243 Unc93b1 WT/WT , Unc93b1 WT/PKP , and Unc93b1 PKP/PKP mice ( Fig. S6c ).
244
To test whether TLR7 function is required for the disease in Unc93b1 PKP/PKP mice we 
251
These findings identify a new mechanism that specifically limits TLR7 signaling and 252 consequently prevents responses against self-RNA. We propose a model whereby the C-terminal tail of 253 Unc93b1 binds the negative regulator Syntenin-1, which is further recruited upon TLR7 activation and 254 controls the threshold of TLR7 signaling (Fig. 6 ). Disrupting the binding site or recruitment of Syntenin-1 255 through mutations in Unc93b1 results in uncontrolled TLR7 responses that lead to a break in self-256 tolerance and autoimmunity. Syntenin-1 has been previously described as a versatile adaptor protein that 257 regulates multiple signaling complexes in the cell. Our work suggests that Syntenin-1 can interfere with 258 TLR7 signaling directly. This inhibition acts early in TLR7 signaling, affecting assembly of the 259 Myddosome and subsequent downstream signaling. The precise mechanism by which Syntenin-1 inhibits 260 Myddosome assembly remains unclear, but it seems likely that binding of Syntenin-1 to one or more 261 signaling components prevents stable assembly of the multi-protein complex. Thus, Unc93b1 appears to 262 serve as a regulatory scaffolding protein, bridging TLR7 with a negative regulator that prevents signal 263 initiation.
264
Previously described functions of Unc93b1 have been limited to control of TLR trafficking; our 265 work clearly expands the scope of Unc93b1 function and suggests that this protein controls TLR function 266 at multiple levels. One particularly interesting aspect of the mechanism we describe here is its selectivity 267 for regulation of TLR7, especially considering the differential roles played by TLR7 and TLR9 in mouse 268 models of SLE. The disease observed in Unc93b1 PKP/PKP mice was entirely TLR7 dependent, and there 269 was no evidence of enhanced TLR9 signaling in these mice. In an accompanying manuscript 28 , we 270 describe a mechanism that explains this selectivity: while Unc93b1 remains associated with TLR7 in 271 endosomes, TLR9 is released and is therefore no longer subject to inhibition by Syntenin-1. Thus, our 272 work provides the first mechanistic basis for differential regulation of TLR7 and TLR9, which may be 273 relevant for human autoimmune diseases. We demonstrate that genetic variants in the C-terminal tail of 274 human Unc93b1 can alter TLR7 responses, but even more intriguing is the possibility that Syntenin-1 275 recruitment to Unc93b1 can be dynamically controlled through phosphorylation or dephosphorylation of 276 Ser547 and Ser550. Identifying the players involved in this regulation should reveal critical determinants 277 that influence self versus non-self discrimination.
278

Methods
280
Antibodies and Reagents
281
The following antibodies were used for immunoblots and immunoprecipitations: anti-HA as purified 282 antibody or matrix (3F10, Roche), anti-FLAG as purified antibody or matrix (M2, Sigma-Aldrich), anti- 
305
The antibody against phosphorylated Unc93b1 was generated by Invitrogen against synthesized 
358
To generate HEK293T Unc93b1 -/cells, guide RNAs were designed and synthesized as gBlocks 
505
Proteins were simultaneously extracted from a gel slice and digested with trypsin, and the resulting 506 peptides were dried and resuspended in buffer A (5% acetonitrile/ 0.02% heptaflurobutyric acid (HBFA)).
507
A nano LC column that consisted of 10 cm of Polaris c18 5 µm packing material (Varian) was packed in a 508 100 µm inner diameter glass capillary with an emitter tip. After sample loading and washed extensively 509 with buffer A, the column was then directly coupled to an electrospray ionization source mounted on a (a) Unc93b1 C-terminal mutants show enhanced TLR7 responses. Representative flow cytometry analysis showing percent TNFα positive cells, measured by intracellular cytokine staining, of Unc93b1-deficient RAW macrophages retrovirally transduced to express the indicated Unc93b1 alleles after stimulation with CpG-B (100 nM) for TLR9, R848 (10 ng/ml) and ssRNA40 (2.5 µg/ml) for TLR7, PolyIC (20 µg/ml) for TLR3, or LPS (10 ng/ml) for TLR4. (b,c) TNFα production, measured by ELISA, from the indicated RAW macrophage lines after stimulation for 8h with R848 (10 ng/ml), ssRNA40 (1 µg/ml), CpG-B (25 nM), LPS (50 ng/ml), or increasing concentrations of R848 (n=3; representative of three independent repeats). (d) Domain structure of Unc93b1 with the C-terminal regulatory region indicated in orange. (e) Unc93b1 PKP -expressing macrophages show enhanced TLR7 signaling. Immunoblot of P-p38, P-JNK, P-ERK, and IκBα of RAW macrophages stimulated with R848 (50 ng/ml) for indicated times. Representative of two independent experiments. (f) Enhanced Myddosome assembly in Unc93b1 PKP macrophages. Immunoprecipitation of MyD88 from RAW macrophage lines expressing the indicated Unc93b1 alleles and stimulated with R848 (500 ng/ml), for indicated times followed by immunoblot for IRAK2. Input levels of Myd88 and IRAK2 in whole cell lysates (WCL) are also shown. (g) TLR7 and TLR9 trafficking are normal in Unc93b1 PKP but not in Unc93b1 D34A RAW lines. Immunoblot of TLR7 and TLR9 from lysates of indicated RAW macrophage lines. All data are mean ± SD; *p < 0.05, **p < 0.01, ***p < 0.001 by unpaired Student's t-test. The data are representative of at least three independent experiments, unless otherwise noted.
Fig. 2. Unc93b1 PKP does not alter TLR7 trafficking or localization.
(a) Unc93b1 PKP does not alter TLR7 export rates. Pulse-chase analysis of TLR7 in Unc93b1 WT and Unc93b1 PKPexpressing RAW macrophages. Cell lysate was HA immunoprecipitated and subjected to radiolabeled screen and immunoblot. The full-length and cleaved forms of TLR7 are indicated. An asterisk denotes a nonspecific band. Representative of two independent experiments. (b) Unc93b1 PKP does not affect TLR7 trafficking to endosomes. Levels of TLR7, Lamp1, and Calnexin in whole cell lysates (WCL) or lysates of purified phagosomes from the indicated RAW macrophage lines were measured by immunoblot. Representative of three independent experiments. (c) Colocalization of TLR7 and Lamp1 in RAW macrophages expressing the indicated Unc93b1 alleles on a Myd88 -/background using superresolution structured illumination microscopy. Shown are representative Unc93b1 WT , Unc93b1 HR and Unc93b1 PKP cells: TLR7 (red) and Lamp1 (green). Boxed areas are magnified. The plot shows quantification of the percentage of total TLR7 within Lamp1 + endosomes with each dot representing an individual cell (pooled together from two independent experiments). Scale bars: 10 µm. All data are mean ± SD; *p < 0.05, **p < 0.01, ***p < 0.001 by unpaired Student's t-test.
Fig. 3. Syntenin-1 binds to the C-terminal tail of Unc93b1 and restricts TLR7 signaling.
(a) Silver stained SDS-PAGE gel of purified Unc93b1-FLAG complexes in phagosomes enriched from RAW macrophages expressing the indicated Unc93b1 alleles. Note the 32kD protein (subsequently identified as Syntenin-1) that is less abundant in Unc93b1 PKP complexes. (b) Syntenin-1 binds Unc93b1 WT . Purified Unc93b1-FLAG complexes described in (a) were immunoblotted for Syntenin-1. (c) Syntenin-1 is recruited to wildtype Unc93b1 but not Unc93b1 PKP . Syntenin-1 binding to Unc93b1 was measured by FLAG immunoprecipitation followed by immunoblot for Syntenin-1 from RAW macrophage lines stimulated with R848 (0.5 µg/ml) for the indicated times. Levels of Syntenin-1 and Unc93b1-FLAG in cell lysates are also shown. (d-e) Syntenin-1 suppresses TLR7 signaling. (d) NFκB activation in HEK293T cells transiently expressing TLR7 and increasing amounts of Syntenin-1 was measured using a dual luciferase reporter assay. Cells were stimulated with R848 (50 ng/ml) for 16 h prior to harvest. On-way ANOVA results: F(4/10)=48.4, p<0.0001 (e) HEK293T cells transiently expressing Syntenin-1 and stimulated with TNFα (10 ng/ml); F(5/12)=1.263, p=ns. Data are normalized to Renilla expression and expressed as relative luciferase units (RLU) (n=3-4, representative of three independent experiments). (f) Syntenin-1 is selectively recruited to Unc93b1 upon TLR7 stimulation. Interaction between Syntenin-1 and Unc93b1 was measured as described in (c) from Unc93b1 WT RAW macrophages stimulated with R848 (0.5 µg/ml) or CpG-B (0.5 µM) for the indicated times. All data are mean ± SD and were analyzed with one-way ANOVA followed by a Tukey's posttest (95% confidence interval): *p < 0.05, **p < 0.01, ***p < 0.001. The data are representative of at least three independent experiments. Representative flow cytometry analysis showing percent TNFα positive cells, measured by intracellular cytokine staining, of Unc93b1-deficient RAW macrophages complemented with the indicated mutant alleles and stimulated with CpG-B (10 nM) for TLR9, R848 (10 ng/ml) and ssRNA40 (1 µg/ml) for TLR7, PolyIC (20 µg/ml) for TLR3, or LPS (10 ng/ml) for TLR4. (b) TNFα production, measured by ELISA, from the indicated RAW macrophage lines after stimulation for 8 h with R848 (20 ng/ml), or LPS (50 ng/ml) (n=3; representative of three independent experiments. One-way ANOVA results for R848 groups: F(5/12)=247.2, p<0.0001; LPS groups: F(5/12)=93.59, p<0.0001). (c) Levels of phospho-p38 and phospho-JNK, as measured by immunoblot, in lysates of the indicated RAW macrophage cells stimulated with R848 (50 ng/ml). (d) Phosphorylation of Ser547 and Ser550 is required for Syntenin-1 binding to Unc93b1. Syntenin-1 binding to Unc93b1 WT or Unc93b1 S547A/S550A in RAW macrophages stimulated with R848 (0.5 µg/ml) was measured by Unc93b1-FLAG immunoprecipitation followed by immunoblot for Syntenin-1. Levels of Syntenin-1 and Unc93b1-FLAG in cell lysates are also shown. (e) Unc93b1 PKP is phosphorylated. Unc93b1-FLAG was immunoprecipitated from lysates of the indicated RAW macrophage lines and phosphorylation of Ser547 and Ser550 was measured by immunoblot with phospho-specific antibodies. Each blot was performed on the same membrane but cropped to present relevant lanes. (f) A model of Syntenin-mediated TLR7 restriction. (g) Genetic variation in the human Unc93b1 C-terminal regulatory region increases TLR7 responses. NFκB activation in HEK293T cells transiently expressing TLR7 or TLR5 and the indicated human Unc93b1 alleles was measured using a dual luciferase reporter assay. Cells were stimulated with R848 (10 ng/ml) or ultrapure Flagellin (2 ng/ml) for 16 h prior to harvest. Data are normalized to Renilla expression and expressed as relative luciferase units (RLUs) (n=4, representative of three independent experiments. On-way ANOVA results for TLR7 groups: F(4/10)=20.03, p<0.0001; TLR5 groups: F(4/10)=28.69, p<0.0001). All data are mean ± SD; data were analyzed with one-way ANOVA followed by a Tukey's posttest (95% confidence interval): *p < 0.05, **p < 0.01, ***p < 0.001. The data are representative of at least three independent experiments, unless otherwise noted. (10 ng/ml) and ssRNA40 (1 µg/ml) for TLR7, PolyIC (20 µg/ml) for TLR3, or LPS (10 ng/ml) for TLR4. Representative of three independent experiments. (b) TNFα production, measured by ELISA, from the indicated RAW macrophage lines after stimulation for 8h with R848 (10 ng/ml), CpG-B (25 nM), or LPS (50 ng/ml) (n=3, representative of two independent experiments). All data are mean ± SD; *p < 0.05, **p < 0.01, ***p < 0.001 by unpaired Student's t-test. Fig. S3 : The sub-cellular localization of Unc93b1 PKP is not altered relative to Unc93b1 WT . Colocalization of Unc93b1 (red) and Lamp1 (green) was measured using superresolution structured illumination microscopy in Unc93b1-deficient RAW macrophages complemented with Unc93b1 WT , Unc93b1 PKP , or Unc93b1 H412R . A representative cell is shown for each Unc93b1 allele. Boxed areas are magnified. The plot shows quantification of the percentage of total Unc93b1 within Lamp1 + endosomes with each dot representing an individual cell (imaged in a single experiment). Scale bars: 10µm. Data is presented as mean ± SD; **p < 0.01 by unpaired Student's t-test. (a) Immunoblots demonstrating the specificity of the phosphospecific antibodies generated against Ser547 and Ser550 in the Unc93b1 C-tail. Varying quantities of synthesized peptides corresponding to the Unc93b1 Cterminal regulatory region with (P-Unc93b1-C) and without (NP-Unc93b1-C) phosphorylated Ser547 and Ser550 were blotted to membrane and probed with rabbit phospho-specific, affinity-purified polyclonal IgG. Representative of two independent experiments. (b) The phospho-specific polyclonal antibody detects both phosphorylated Ser547 and Ser550. Unc93b1 was isolated from Unc93b1-deficient RAW macrophages expressing Unc93b1 S547A , Unc93b1 S550A , or Unc93b1 S547A/S550A by FLAG immunoprecipitation followed by immunoblot with the phospho-specific polyclonal antibody. Representative of at least three independent experiments.
Fig. S6: Unc93b1 PKP knock-in mice develop systemic inflammation.
(a) CRISPR/Cas-9 strategy to generate Unc93b1 PKP knock-in mice. (b) Representative flow cytometry analysis showing percent TNFα positive cells, measured by intracellular cytokine staining, of bone marrow-derived macrophages derived from Unc93b1 WT/WT , Unc93b1 PKP/WT , and Unc93b1 PKP/PKP mice after stimulation with CpG-B (150 nM) for TLR9, R848 (10 ng/ml) for TLR7, PolyIC (10 µg/ml) for TLR3, or LPS (10 ng/ml) for TLR4. (c)
